- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02150174
Testing Effect and Schizophrenia
Retrieval Practice in Patients With Schizophrenia : an Exploratory Study Using Word Pairs
When people are tested on a previously learned material, they will latter remember it better even when compared to a condition where they can re-study it. This phenomenon is called retrieval practice and is supported by an extensive research literature mostly carried out in normal students. This paradigm begins to be used in cognitive remediation programs in patients suffering from memory difficulties.
The objective of this study is to investigate whether retrieval practice is spared in patients with schizophrenia.
If effective, this method could be used in cognitive remediation programs.
Since episodic memory difficulties are supposed to be secondary to deficits in the initiation/elaboration of efficient encoding and retrieval strategies our hypothesis is that retrieval practice is spared in schizophrenia
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Laxou, France, 54521
- Centre Psychothérapique de Nancy
-
Strasbourg, France, 67091 Cedex
- Service de psychiatrie - Hôpital Civil - CHRU Strasbourg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- French is the native language, or acquired before 5 years old
- People must be able to understand and follow the trial instructions
Specific inclusion criteria (for patients) :
- Diagnostic of schizophrenia, according to the DSM -5, clinically stable
- The treatment must remain unchanged during the trial
Exclusion Criteria:
- Severe or acute cerebral disease
- Other actual psychiatric disorder
- Use of drugs with high anticholinergic effect
- Irregular use of benzodiazepines medication, or high dose of benzodiazepin (more than 2 mg of lorazepam per day or equivalent)
- Inappropriate use of drugs
Specific exclusion criteria (for healthy subjects) :
- Diagnostic of schizophrenia of a relative up to the third degree
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Healthy subjects
|
In the first phase (encoding), people study a list of 48 word pairs non semantically associated. Then (initial test), they recall half of word pairs or restudy the other half. In the second phase (final test) which takes place 2 days later, they recall all the 48 the word pairs. |
|
Experimental: Patients with schizophrenia
|
In the first phase (encoding), people study a list of 48 word pairs non semantically associated. Then (initial test), they recall half of word pairs or restudy the other half. In the second phase (final test) which takes place 2 days later, they recall all the 48 the word pairs. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of word pairs properly recalled
Time Frame: Final test : 2 days after the first experimental session
|
- The aim is to investigate the retrieval practice effect using word pairs and cued recall tests with feedback in patients with schizophrenia and healthy controls. In the first phase (encoding), people study a list of 48 word pairs non semantically associated, then half of the pairs are presented in its completed form for two times, and for the other half the two subsequent re-exposure trials are framed as cued recall tests (the first word is presented and the subject has to remember and give orally the second word, and a feedback is given). In the second phase (final test) which takes place 2 days later, all the 48 word pairs are presented as a cued recall test. - We will compare in patients with schizophrenia and healthy controls final performance recall for information studied and recalled ("test" condition) to those for information studied and then re-studied ("re-study" condition). |
Final test : 2 days after the first experimental session
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference between final performance recall and memory span score
Time Frame: Final test : 2 days after the first experimental session
|
In each group (patients with schizophrenia and healthy controls) : Difference between the final performance recall (see primary outcome measure) in "test" condition and "re-study" condition AND memory span score. |
Final test : 2 days after the first experimental session
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 5806
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States
-
Bradley LegaRecruiting
-
Central Institute of Mental Health, MannheimRecruitingSchizophrenia | Treatment Resistant SchizophreniaGermany
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Elazığ Mental Health and Diseases HospitalCompleted
-
Dr. Lutfi Kirdar Kartal Training and Research HospitalCompletedSchizophrenia DisorderTurkey (Türkiye)
Clinical Trials on Retrieval practice effect using word pairs and cued recall tests with feedback
-
University Hospital, Strasbourg, FranceSuspended